Navigation Links
New alliance for European excellence and competitiveness in life sciences
Date:5/28/2013

Tomorrow, at the Centre for Genomic Regulation (CRG), in Barcelona, directors and staff from ten top European research institutes will kick off a new alliance, called EU-LIFE, that will promote European research. The mission of EU-LIFE is to foster excellence, share knowledge, and influence policies in life sciences. Partners in EU-LIFE are renowned research centers that operate with similar principles of excellence, external reviews, independence, competiveness, and internationality. During difficult economic times and within a highly competitive international research landscape, they believe that they can join forces to better address complex questions, thereby contributing to pushing European science forward.

Why are we often not able to attract top students from the US? Why do many of our junior talents leave to other continents and don't return?", reflects Luis Serrano, director of the Centre for Genomics Regulation (CRG, Spain) and one of the co-founders of this initiative. "There are many excellent research institutes in Europe. By increasing our international visibility through EU-LIFE, we aim to raise awareness for European science. Instead of working independently, we want to coordinate our efforts to create added value for Europe. We envision, for example, to agree on common standards for Ph.D. and postdoctoral recruitment and training programmes, and to organize joint scientific events for young scientists.

During the official launch of EU-LIFE tomorrow, at the CRG, Fabienne Gautier, Head of Unit of the European Research Area at the European Commission, will discuss how a network like EU-LIFE can be a key player in fostering European excellence and competitiveness in research. During the meeting, more than 60 EU-LIFE members will actively work to define concrete actions needed to reach their ambitious goals. Specific working groups will brainstorm, share best practice, and design joint activities in technology transfer, international collaboration, translational research, science communication, competitive funding, recruitment, and training. The meeting will be an intensive and rewarding exercise to start building ties across institutes, countries, cultures, and areas of expertise.

Current partners of this association are the co-leaders CRG and VIB (Belgium), the Institut Curie (France), the Netherlands Cancer Institute (Netherlands), the Max Delbrck Center for Molecular Medicine; MDC, Berlin-Buch (Germany), Istituto Europeo di Oncologia (Italy), Instituto Gulbenkian de Cincia (Portugal), the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (Austria), CEITEC (Czech Republic), and the Institute for Molecular Medicine Finland (Finland).


'/>"/>

Contact: Laia Cendrós
laia.cendros@crg.eu
34-933-160-237
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Related biology news :

1. Dolphins cultivate loose alliances
2. Phoenix Community Alliance honors TGens Dr. Jeffrey Trent
3. NSF research alliances begin new efforts to accelerate innovation
4. Viral alliances overcoming plant defenses
5. Core for Life, a new European alliance in biomedical research
6. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
7. An invasive Asian fly is taking over European fruit
8. Building the European Unions Natura 2000 -- the largest ever network of protected areas
9. European grasslands challenge rainforests as the most species-rich spaces on Earth
10. European mountain plant population shows delayed response to climate change
11. European Society of Human Reproduction and Embryology 28th Annual Meeting -- Istanbul
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: